Year-end Sale % OFF 
Abstract
Background & purpose: Patients with estrogen receptor (ER) positive breast cancer may be treated with primary endocrine therapy (PET) if they wish to avoid an operation or are deemed unsuitable for a general anaesthetic 1. Surgery, chemotherapy and radiotherapy may reduce overall quality of life without improvement in survival, particularly if treatment complications occur. The aim of PET is to prevent progression of disease, so that these patients die with rather than from breast cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
